As of 2024-12-12, the Relative Valuation of Black Diamond Therapeutics Inc (BDTX) is (23.90) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.52 USD, the upside of Black Diamond Therapeutics Inc based on Relative Valuation is -1048.3%.
The range of the Relative Valuation is (14.54) - (25.09) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.0x - 24.9x | 18.3x |
| Forward P/E multiples | 11.3x - 19.4x | 18.7x |
| Fair Price | (14.54) - (25.09) | (23.90) |
| Upside | -677.2% - -1095.5% | -1048.3% |
| Date | P/E |
| 2024-11-29 | -2.05 |
| 2024-11-27 | -1.99 |
| 2024-11-26 | -1.91 |
| 2024-11-25 | -1.94 |
| 2024-11-22 | -1.97 |
| 2024-11-21 | -1.88 |
| 2024-11-20 | -1.88 |
| 2024-11-19 | -1.97 |
| 2024-11-18 | -1.94 |
| 2024-11-15 | -2.03 |
| 2024-11-14 | -2.21 |
| 2024-11-13 | -2.42 |
| 2024-11-12 | -2.51 |
| 2024-11-11 | -2.62 |
| 2024-11-08 | -2.55 |
| 2024-11-07 | -2.46 |
| 2024-11-06 | -2.55 |
| 2024-11-05 | -2.52 |
| 2024-11-04 | -2.31 |
| 2024-11-01 | -2.24 |
| 2024-10-31 | -2.12 |
| 2024-10-30 | -2.22 |
| 2024-10-29 | -2.21 |
| 2024-10-28 | -2.26 |
| 2024-10-25 | -2.31 |
| 2024-10-24 | -2.35 |
| 2024-10-23 | -2.37 |
| 2024-10-22 | -2.56 |
| 2024-10-21 | -2.49 |
| 2024-10-18 | -2.56 |
| 2024-10-17 | -2.49 |
| 2024-10-16 | -2.63 |
| 2024-10-15 | -2.63 |
| 2024-10-14 | -2.69 |
| 2024-10-11 | -2.58 |
| 2024-10-10 | -2.66 |
| 2024-10-09 | -2.75 |
| 2024-10-08 | -2.75 |
| 2024-10-07 | -2.83 |
| 2024-10-04 | -2.90 |
| 2024-10-03 | -2.83 |
| 2024-10-02 | -3.09 |
| 2024-10-01 | -3.23 |
| 2024-09-30 | -3.37 |
| 2024-09-27 | -3.27 |
| 2024-09-26 | -3.41 |
| 2024-09-25 | -3.25 |
| 2024-09-24 | -3.55 |
| 2024-09-23 | -3.48 |
| 2024-09-20 | -3.68 |